Combining neuroprotectants in a model of retinal degeneration: no additive benefit.

The central nervous system undergoing degeneration can be stabilized, and in some models can be restored to function, by neuroprotective treatments. Photobiomodulation (PBM) and dietary saffron are distinctive as neuroprotectants in that they upregulate protective mechanisms, without causing measura...

Full description

Bibliographic Details
Main Authors: Fabiana Di Marco, Mattia Di Paolo, Stefania Romeo, Linda Colecchi, Lavinia Fiorani, Sharon Spana, Jonathan Stone, Silvia Bisti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4067315?pdf=render
id doaj-cdf1ac33ba194c23874b00de04eae317
record_format Article
spelling doaj-cdf1ac33ba194c23874b00de04eae3172020-11-25T01:12:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e10038910.1371/journal.pone.0100389Combining neuroprotectants in a model of retinal degeneration: no additive benefit.Fabiana Di MarcoMattia Di PaoloStefania RomeoLinda ColecchiLavinia FioraniSharon SpanaJonathan StoneSilvia BistiThe central nervous system undergoing degeneration can be stabilized, and in some models can be restored to function, by neuroprotective treatments. Photobiomodulation (PBM) and dietary saffron are distinctive as neuroprotectants in that they upregulate protective mechanisms, without causing measurable tissue damage. This study reports a first attempt to combine the actions of PBM and saffron. Our working hypothesis was that the actions of PBM and saffron in protecting retinal photoreceptors, in a rat light damage model, would be additive. Results confirmed the neuroprotective potential of each used separately, but gave no evidence that their effects are additive. Detailed analysis suggests that there is actually a negative interaction between PBM and saffron when given simultaneously, with a consequent reduction of the neuroprotection. Specific testing will be required to understand the mechanisms involved and to establish whether there is clinical potential in combining neuroprotectants, to improve the quality of life of people affected by retinal pathology, such as age-related macular degeneration, the major cause of blindness and visual impairment in older adults.http://europepmc.org/articles/PMC4067315?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Fabiana Di Marco
Mattia Di Paolo
Stefania Romeo
Linda Colecchi
Lavinia Fiorani
Sharon Spana
Jonathan Stone
Silvia Bisti
spellingShingle Fabiana Di Marco
Mattia Di Paolo
Stefania Romeo
Linda Colecchi
Lavinia Fiorani
Sharon Spana
Jonathan Stone
Silvia Bisti
Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
PLoS ONE
author_facet Fabiana Di Marco
Mattia Di Paolo
Stefania Romeo
Linda Colecchi
Lavinia Fiorani
Sharon Spana
Jonathan Stone
Silvia Bisti
author_sort Fabiana Di Marco
title Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
title_short Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
title_full Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
title_fullStr Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
title_full_unstemmed Combining neuroprotectants in a model of retinal degeneration: no additive benefit.
title_sort combining neuroprotectants in a model of retinal degeneration: no additive benefit.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The central nervous system undergoing degeneration can be stabilized, and in some models can be restored to function, by neuroprotective treatments. Photobiomodulation (PBM) and dietary saffron are distinctive as neuroprotectants in that they upregulate protective mechanisms, without causing measurable tissue damage. This study reports a first attempt to combine the actions of PBM and saffron. Our working hypothesis was that the actions of PBM and saffron in protecting retinal photoreceptors, in a rat light damage model, would be additive. Results confirmed the neuroprotective potential of each used separately, but gave no evidence that their effects are additive. Detailed analysis suggests that there is actually a negative interaction between PBM and saffron when given simultaneously, with a consequent reduction of the neuroprotection. Specific testing will be required to understand the mechanisms involved and to establish whether there is clinical potential in combining neuroprotectants, to improve the quality of life of people affected by retinal pathology, such as age-related macular degeneration, the major cause of blindness and visual impairment in older adults.
url http://europepmc.org/articles/PMC4067315?pdf=render
work_keys_str_mv AT fabianadimarco combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT mattiadipaolo combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT stefaniaromeo combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT lindacolecchi combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT laviniafiorani combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT sharonspana combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT jonathanstone combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
AT silviabisti combiningneuroprotectantsinamodelofretinaldegenerationnoadditivebenefit
_version_ 1725167808299401216